Effect of umbilical cord serum coated 3D PCL/alginate scaffold for mastoid obliteration

International Journal of Pediatric Otorhinolaryngology

Volumn 78, Issue 7, 2014, Pages 1061-1065

  Jang, Chul Ho ^a,b   Cho, Yong Beom ^a   Choi, Cheol Hee ^b   Jang, Yoon Seok ^b   Jung, Won Kyo ^c   Lee, Hyeongjin ^d   Kim, Geun Hyung ^d  

^a Chonnam National University Medical School   (South Korea)

^b Chosun University   (South Korea)

^c Pukyong National University   (South Korea)

^d Sungkyunkwan University   (South Korea)

Author keywords

Mastoid obliteration; Osteogenesis; Polycaprolactone; Umbilical cord serum

Indexed keywords

ALGINIC ACID; ALIZARIN; POLYCAPROLACTONE; TISSUE SCAFFOLD; BIOMATERIAL; POLYESTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; CONTROLLED STUDY; EX VIVO STUDY; GUINEA PIG; HISTOLOGY; HUMAN; MALE; MASTOID OBLITERATION; MASTOIDECTOMY; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STEREOMICROSCOPY; UMBILICAL CORD BLOOD; ANIMAL; BONE DEVELOPMENT; CHEMISTRY; FETUS BLOOD; MASTOID; PATHOLOGY; PROCEDURES; SURGERY; TISSUE ENGINEERING; TISSUE SCAFFOLD;

ALGINATES; ANIMALS; COATED MATERIALS, BIOCOMPATIBLE; FETAL BLOOD; GUINEA PIGS; HUMANS; MALE; MASTOID; MICROSCOPY, ELECTRON, SCANNING; OSTEOGENESIS; POLYESTERS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; X-RAY MICROTOMOGRAPHY;

EID: 84902116630     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2014.04.004     Document Type: Article

References (27)

1. Moffat D.A., Gray R.F., Irving R.M. Mastoid obliteration using bone pate. Clin. Otol. 1994, 19:149-157.
2. Mahendran S., Yung M.W. Mastoid obliteration with hydroxyapatite cement: the Ipswich experience. Otol. Neurotol. 2004, 25:19-21.
3. Yung M., Smith P. Mid-temporal pericranial and inferiorly based periosteal flaps in mastoid obliteration. Otolaryngol. Head Neck Surg. 2007, 137:906-912.
4. Matsuno T., Nakamura T., Kuremoto K., Notazawa S., Nakahara T., Hashimoto Y., et al. Development of β-tricalcium phosphate/collagen sponge composite for bone tissue regeneration. Dent. Mater. J. 2006, 25:138-144.
5. Jang C.H., Park H., Cho Y.B., Song C.H. Mastoid obliteration using a hyaluronic acid gel to deliver a mesenchymal stem cells-loaded demineralized bone matrix: an experimental study. Int. J. Pediatr. Otorhinolaryngol. 2008, 72:1627-1632.
6. Jang C.H., Cho Y.B., Yang H.C., Kim J.S., Choi C.H., Jang S.J., et al. Effect of piperacillin-tazobactam coated β-tricalcium phosphate for mastoid obliteration in otitis media. Int. J. Pediatr. Otorhinolaryngol. 2011, 75:631-634.
7. Jang C.H., Cho Y.B., Bae C.S. Evaluation of bioactive glass for mastoid obliteration: a guinea pig model. In Vivo 2007, 21:651-655.
8. Yanagihara N., Komori M., Hinohira Y. Total mastoid obliteration in staged canal-up tympanoplasty for cholesteatoma facilitates tympanic aeration. Otol. Neurotol. 2009, 30:766-770.
9. Jang C.H. Changes in external ear resonance after mastoidectomy: open cavity mastoid versus obliterated mastoid cavity. Clin. Otolaryngol. Allied Sci. 2002, 27:509-511.
10. Ma G., Song C., Sun H., Yang J., Leng X. In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method. Biomaterials 2007, 28:1664-1671.
11. Petrie Aronin C.E., Cooper J.A., Sefcik L.S., Tholpady S.S., Ogle R.C., Botchwey E.A. Osteogenetic differentiation of dura mater stem cells cultured in vitro on three-dimensional porous scaffolds of poly(epsilon-caprolactone) fabricated via coextrusion and gas foaming. Acta Biomater. 2008, 4:1187-1197.
12. Rai B., Oest M.E., Dupont K.M., Ho K.H., Teoh S.H., Guldber R.E. Combination of platelet-rich plasma with polycaprolactone-tricalcium phosphate scaffolds for segmental bone defect repair. J. Biomed. Mater. Res. A 2007, 15(81):888-899.
13. Cipitria A., Lange C., Schell H., Wagermaier W., Reichert J.C., Hutmacher D.W., et al. Porous scaffold architecture guides tissue formation. J. Bone Miner. Res. 2012, 27:1275-1288.
14. Mekala N.K., Baadhe R.R., Parcha S.R., Prameela D.Y. Physical and degradation properties of PLGA scaffolds fabricated by salt fusion technique. J. Biomed. Res. 2013, 27:318-325.
15. Bagherzadeh R., Latifi M., Kong L. Three-dimensional pore structure analysis of polycaprolactone nano-microfibrous scaffolds using theoretical and experimental approaches. J. Biomed. Mater. Res. A 2014, 102:903-910.
16. Jang C.H., Cho Y.B., Yeo M.G., Kim G.H. Mastoid obliteration using three-dimensional composite scaffolds consisting of polycaprolactone/β-tricalcium phosphate/collagen nanofibers: an in vitro and in vivo study. Macromol. Biosci. 2013, 13:660-668.
17. Hutmacher D.W., Schantz T., Zein I., Ng K.W., Teoh S.H., Tan K.C. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modelling. J. Biomed. Mater. Res. 2001, 55:203-216.
18. Schucker K.H., Jopp S., Teoh S.H. Mandibular defect reconstruction using three-dimensional polycaprolactone scaffold in combination with platelet-rich plasma and recombinant human bone morphogenetic protein-2: de novo synthesis of bone in a single case. Tissue Eng. Part A 2009, 15:493-499.
19. Jones E., English A., Churchman S.M., Kouroupis D., Boxall S.A., Kinsey S., et al. Large-scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells. Arthritis Rheum. 2010, 62:1944-1954.
20. Nishizaki K., Tsujigiwa H., Takeda Y., Yoshino T., Maeta M., Fukushima K., et al. Mastoid obliteration by BMP-2/collagen composites: an experimental study using tissue engineering. Am. J. Otolaryngol. 2003, 24:14-18.
21. Kakehata S., Hirose Y., Kitani R., Futai K., Maruya S., Ishii K., et al. Autologous serum ear drops therapy with a chitin membrane for closing tympanic membrane perforations. Otol. Neurotol. 2008, 29:791-795.
22. Poon A.C., Geerling G., Dart J.K., Fraenkel G.E., Daniels J.T. Autologous serum eyedrops for dry eye and epithelial defect: clinical and in vitro toxicity studies. Br. J. Ophthalmol. 2001, 85:1188-1197.
23. Yoon K.C., Im S.K., Park Y.G., Jung Y.D., Yang S.Y., Choi J. Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome. Cornea 2006, 25:268-272.
24. Vajpayee R.B., Mukeriji N., Tandon R., Sharma N., Pandey R.M., Biswas N.R., et al. Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br. J. Ophthalmol. 2003, 87:1312-1316.
25. Sharma N., Goel M., Velpandian T., Titiyal J.S., Tandon R., Vajpayee R.B. Evaluation of umbilical cord serum therapy in acute ocular chemical burns. Invest. Ophthalmol. Vis. Sci. 2011, 52:1087-1092.
26. Jang C.H., Kim M.S., Cho Y.B., Jang Y.S., Kim G.H. Mastoid obliteration using 3D PCL scaffold in combination wit alginate and rhBMP-2. Int. J. Biol. Macromol. 2013, 62:614-622.
27. Ohishi W., Fujiwara S., Suzuki G., Kishi T., Sora M., Matsuura S., et al. Feasibility of freeze-dried sera for serological and molecular biological detection of hepatitis B and C viruses. J. Clin. Microbiol. 2006, 44:4593-4595.